The effect of unintended shortage in technical resources on the quality of endpoint clinical laboratory diagnosis

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Rapid rule-in and rule-out protocols of acute myocardial infarction using hs-cTnI and hs-cTnT methods
4. Reviews
5. A guide to conducting systematic reviews of clinical laboratory tests
6. Improving diagnosis and treatment of hypomagnesemia
7. Opininon Paper
8. Documenting and validating metrological traceability of serum alanine aminotransferase measurements: a priority for medical laboratory community for providing high quality service in hepatology
9. EFLM Paper
10. Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: insights from the 2022 EFLM Task Group on CKD survey
11. General Clinical Chemistry and Laboratory Medicine
12. Bland and Altman agreement method: to plot differences against means or differences against standard? An endless tale?
13. Assessment of three equations to calculate plasma LDL cholesterol concentration in fasting and non-fasting hypertriglyceridemic patients
14. Validation of metrological traceability of the new generation of Abbott Alinity alkaline phosphatase assay
15. Quality assurance programs for vitamin A and E in serum: are we doing enough to assess laboratory performance?
16. A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents
17. Performance evaluation of alternate ESR measurement method using BC-780 automated hematology analyzer: a comparison study with the Westergren reference method
18. Total error in lymphocyte subpopulations by flow cytometry-based in state of the art using Spanish EQAS data
19. Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury
20. CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa^® assays targeting distinct amyloid regions
21. Improving regional medical laboratory center report quality through a report recall management system
22. Cardiovascular Diseases
23. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay
24. Hemodialysis and biomarkers of myocardial infarction – a cohort study
25. Letters to the Editor
26. Chatbot GPT can be grossly inaccurate
27. Blood collection in heparin vs. EDTA results in an inflammasome-independent increase in monocyte distribution width at 4 h
28. Week-to-week within-subject and between-subject biological variation of copeptin
29. The effect of unintended shortage in technical resources on the quality of endpoint clinical laboratory diagnosis
30. Epigenetic signatures of cfDNA enable a topological assignment of tissue damage
31. Six Sigma driven QC in antibody testing for infectious diseases
32. Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor
33. Comment to: Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor
34. Evaluation of serum cortisol measurement by Ortho Vitro after stimulation by ACTH or insulin hypoglycaemia
35. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
36. Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40